How Should Preconceptional Cystic Fibrosis Carrier Screening Be Provided? Opinions of Potential Providers and the Target Population

Publisher： Karger

E-ISSN： 1662-8063|6|3|157-165

ISSN： 1662-4246

Source： Public Health Genomics, Vol.6, Iss.3, 2004-06, pp. : 157-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Offering Preconceptional Cystic Fibrosis Carrier Couple Screening in the Absence of Established Preconceptional Care Services

By  

Public Health Genomics, Vol. 6, Iss. 1, 2003-04 ,pp. : 5-13

Karger

Access to resources Recommend Favorite

Is Cystic Fibrosis Carrier Screening Cost Effective?

By  

Public Health Genomics, Vol. 10, Iss. 2, 2007-03 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Assessing the Potential Success of Cystic Fibrosis Carrier Screening: Lessons Learned from Tay-Sachs Disease and β-Thalassemia

By  

Public Health Genomics, Vol. 13, Iss. 5, 2009-10 ,pp. : 310-319

Karger

Access to resources Recommend Favorite

Preconceptional Screening of Couples for Carriers of Cystic Fibrosis: A Prospective Evaluation of Effects, Costs and Savings for Different Mutation Detection Methods

By  

Public Health Genomics, Vol. 2, Iss. 2-3, 2000-03 ,pp. : 74-81

Karger

Access to resources Recommend Favorite

Population-Based Genetic Screening for Cystic Fibrosis: Attitudes and Outcomes

By  

Public Health Genomics, Vol. 13, Iss. 7-8, 2010-01 ,pp. : 449-456

Karger

Access to resources Recommend Favorite